tiprankstipranks
PFIZER LIMITED (IN:PFIZER)
:PFIZER
India Market
PFIZER
PFIZER LIMITED
RESEARCH TOOLSreports
Want to see IN:PFIZER full AI Analyst Report?

PFIZER LIMITED (PFIZER) Earnings Dates, Call Summary & Reports

118 Followers

Earnings Data

Report Date
Aug 03, 2026
TBA (Confirmed)
Period Ending
2027 (Q1)
Consensus EPS Forecast
―
Last Year’s EPS
41.9
Same Quarter Last Year
Analyst Consensus
―
Based on 0 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Oct 28, 2024|
% Change Since:
|
Earnings Call Sentiment|Positive
Pfizer's earnings call reflected a strong financial performance with solid revenue and EPS growth, driven by effective cost management and advancements in the R&D pipeline. However, challenges such as impacts from the IRA Medicare Part D redesign and ongoing geopolitical uncertainties pose potential risks.
Company Guidance
During Pfizer's Second Quarter 2025 Earnings Conference Call, the company provided updated guidance reflecting strong year-to-date performance. Specifically, Pfizer raised its adjusted diluted EPS guidance for the full year 2025, driven by productivity gains and strategic initiatives to expand margins. The company reported second-quarter revenues of $14.7 billion, a 10% operational increase, and adjusted diluted EPS of $0.78, surpassing expectations. Pfizer's robust operating margins were achieved amidst challenges such as an $825 million unfavorable impact from higher manufacturer discounts due to the IRA Medicare Part D redesign. Pfizer's non-COVID portfolio, including strong performers like the Vyndaqel family and Eliquis, contributed significantly to its solid financial outlook. The company maintained its full-year 2025 revenue guidance of $61 billion to $64 billion and adjusted its SI&A and R&D expense forecasts while expecting an adjusted effective tax rate of approximately 13%. Pfizer's strategic focus remains on enhancing R&D productivity, leveraging AI and digital capabilities, and optimizing capital allocation to create long-term shareholder value.
Strong Revenue Growth
Pfizer recorded revenues of $14.7 billion for the second quarter, representing a 10% operational increase year-over-year.
Increased Earnings Guidance
Pfizer raised its adjusted diluted EPS guidance for the full year 2025 by $0.10, indicating strong performance and confidence in future results.
R&D Pipeline Advancements
Significant progress in the R&D pipeline with promising data for Elrexfio, SV, and Hympavzi, as well as the development of a C. diff vaccine.
Cost Management Success
Total adjusted operating expenses decreased by 8% operationally, demonstrating effective cost management strategies.
Strong Performance of Key Products
Products like Vyndaqel, Eliquis, and Padcev showed significant growth, with Vyndaqel growing 21% year-over-year operationally.

PFIZER LIMITED (IN:PFIZER) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
Daily Earnings Calendar >

IN:PFIZER Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 03, 2026
2027 (Q1)
- / -
41.9―――
May 12, 2026
2026 (Q4)
40.25 / 42.20
43-1.86% (-0.80)――
Feb 09, 2026
2026 (Q3)
36.60 / 40.40
27.944.80% (+12.50)――
Nov 12, 2025
2026 (Q2)
42.60 / 41.30
34.619.36% (+6.70)――
Aug 13, 2025
2026 (Q1)
34.70 / 41.90
32.927.36% (+9.00)――
May 19, 2025
2025 (Q4)
35.85 / 43.00
39.19.97% (+3.90)――
Jan 31, 2025
2025 (Q3)
31.80 / 27.90
27.12.95% (+0.80)――
Oct 28, 2024
2025 (Q2)
37.00 / 34.60
32.66.13% (+2.00)――
Jul 29, 2024
2025 (Q1)
- / 32.90
20.4560.88% (+12.45)――
May 29, 2024
2024 (Q4)
34.70 / 39.10
31.723.34% (+7.40)――
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IN:PFIZER Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 12, 2026
₹4876.95₹4728.90-3.04%
Feb 09, 2026
₹4594.25₹4760.60+3.62%
Nov 12, 2025
₹4996.20₹5020.05+0.48%
Aug 13, 2025
₹5087.05₹5125.80+0.76%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does PFIZER LIMITED (IN:PFIZER) report earnings?
PFIZER LIMITED (IN:PFIZER) is schdueled to report earning on Aug 03, 2026, TBA (Confirmed).
    What is PFIZER LIMITED (IN:PFIZER) earnings time?
    PFIZER LIMITED (IN:PFIZER) earnings time is at Aug 03, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of PFIZER LIMITED stock?
          The P/E ratio of PFIZER LIMITED is N/A.
            What is IN:PFIZER EPS forecast?
            Currently, no data Available